Update :: all eyes on Allergan : drug company's unprecedented move raises questions for patent and drug law (part I) /: Caitlain Devereaux Lewis.

Update : all eyes on Allergan : drug company's unprecedented move raises questions for patent and drug law (part I) / Caitlain Devereaux Lewis.

2018

INTERNET

Formats

E-resource Policy

Linked Resources

Author

Title

Update : all eyes on Allergan : drug company's unprecedented move raises questions for patent and drug law (part I) / Caitlain Devereaux Lewis.

Published

[Washington, District of Columbia] : Congressional Research Service, [2018]

Distributed

[Getzville, New York] : William S. Hein & Company, [2018]

Call Number

INTERNET

Description

1 online resource (4 pages).

System Control No.

(NjRocCCS)ccn00893827

Note

"March 16, 2018."

Digital File Characteristics

text file

Source of Description

Description based on PDF caption title, viewed September 22, 2019.

Series

Record Appears in

Portion of Title

All eyes on Allergan : drug company's unprecedented move raises questions for patent and drug law (part I)

Added Corporate Author